Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

NCT00437086

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloproliferative Disorders, +13 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders

NCT00858572

Conditions: AML, Bone Marrow Diseases, CML, +7 more
Locations: Boston, Massachusetts, United States

New York, United States

San Antonio, Texas, United States

View Trial Details

Completed

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00004258

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Investigation of the Cylex® ImmuKnow® Assay

NCT00569842

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemia, +37 more
Locations: Indiana Universtiy Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

NCT00003961

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

NCT01233921

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +151 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions